About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in the area of data-driven medical insights, help Roche deliver truly personalized healthcare. Roche aims to improve patient access to medical innovations by working with stakeholders across the entire healthcare sector to provide the best care for each person. Roche Canada was founded in 1931, and employs more than 1,800 people across the country through its Pharmaceuticals division in Mississauga, Ontario as well as its Diagnostics and Diabetes Care divisions in Laval, Quebec. Roche continues to search for better ways to prevent, diagnose and treat diseases. Roche Canada is actively involved in local communities through its charitable giving and partnerships with organizations and healthcare institutions that work together to improve the quality of life of Canadians. For more information, please visit www.RocheCanada.com or follow us on Twitter


Peace of mind with constant INNOVATION

Learn more about cobas® pure:

Peace of mind with

Roche is involved in several upcoming regional, national and international conventions that will be published on our Social Media channels. Stay tuned, follow us on Twitter!

Peace of mind with meaningful collaboration and shared purpose

  • Diagnostics Solutions: Increasing patient care with better access to novel high medical value diagnostic solutions
  • Sustainability: For 13 consecutive years, Roche has been recognized as one of the top three most sustainable healthcare companies by the Dow Jones Sustainability Indices. We believe it is our responsibility to care for the environment, contribute to our community, innovate greener solutions and provide a healthy workplace for our employees.
  • Partnership: Together we can shape the future of healthcare. We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether internal or external, and deliver them to patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.